Gilead Sciences' Q4 2024 Financials Show 6% Revenue Growth, Driven by HIV and Oncology
Company

Gilead Sciences’ Q4 2024 Financials Show 6% Revenue Growth, Driven by HIV and Oncology

Lion TCR's Liocyx-M00 Therapy Receives FDA Clearance for HBV-Related HCC Study
CompanyDrug

Lion TCR’s Liocyx-M00 Therapy Receives FDA Clearance for HBV-Related HCC Study

Hainan Poly Pharm's Generic ProHance Wins FDA Approval in US
CompanyDrug

Hainan Poly Pharm’s Generic ProHance Wins FDA Approval in US

Kexing Biopharm and Bio-Thera Solutions Form Alliance for Global Expansion
CompanyDeals

Kexing Biopharm and Bio-Thera Solutions Form Alliance for Global Expansion

MicroPort MedBot's Toumai Surgical Robot Wins NMPA Approval for Single-Hole Laparoscopy
CompanyMedical Device

MicroPort MedBot’s Toumai Surgical Robot Wins NMPA Approval for Single-Hole Laparoscopy

Novartis to Acquire Anthos Therapeutics for $3.1B, Boosting Factor XI Inhibitor Portfolio
CompanyDeals

Novartis to Acquire Anthos Therapeutics for $3.1B, Boosting Factor XI Inhibitor Portfolio

J&J's Rybrevant and Talvey Win Separate NMPA Approvals in China
CompanyDrug

J&J’s Rybrevant and Talvey Win Separate NMPA Approvals in China

Degron Therapeutics' DEG6498 Receives FDA Clearance for Clinical Trials
CompanyDrug

Degron Therapeutics’ DEG6498 Receives FDA Clearance for Clinical Trials

Roche Transfers InterMune and Esbriet to Legacy Pharma in IP Deal
CompanyDeals

Roche Transfers InterMune and Esbriet to Legacy Pharma in IP Deal

Bio-Thera Solutions' BAT1006 Wins NMPA Approval for HER2+ Breast Cancer Trial
CompanyDrug

Bio-Thera Solutions’ BAT1006 Wins NMPA Approval for HER2+ Breast Cancer Trial

China Resources Double-Crane Pharmaceutical Co., Ltd Receives NMPA Approval for Generic Purinethol
CompanyDrug

China Resources Double-Crane Pharmaceutical Co., Ltd Receives NMPA Approval for Generic Purinethol

Henlius Biotech's HLX99 Receives FDA Approval for ALS Clinical Study
CompanyDrug

Henlius Biotech’s HLX99 Receives FDA Approval for ALS Clinical Study